Lipoprotein (a) and Lipoprotein-associated Phospholipase A2 as Atherosclerosis Risk Factors (oxLDL) in Men with Central Obesity
Abstract
BACKGROUND: The increasing prevalence of obesity in Indonesia triggers a lot of research interest to overcome it. Obesity has a very important role as atherosclerosis and cardiovascular risk factors. The presence of oxidized LDL (oxLDL) on the vascular wall is a marker of atherosclerosis. The increase of Lipoprotein(a) (Lp(a)) and Lipoprotein associate phospholipase A2 (LpPLA2) occurs in patients with coronary artery disease (CAD), myocardial infarction, and unstable angina. It is well accepted that obesity is closely related to atherosclerosis and cardiovascular risk factors. However, correlation between Lp(a), LpPLA2 and oxLDL in central obesity has not yet been investigated. The aim of this study was to observing the correlation between Lp(a), LpPLA2 and oxLDL in early central obesity.
METHODS: An observational study with cross-sectional design on 76 men with central obesity, aged 30-67 years, was conducted. Central obesity was characterized by waist circumference >90 cm. Test of Lp(a) was performed by turbidimetric method and that of LpPLA2 was performed by sandwich enzyme immunoassay. Test of oxLDL was performed by ELISA. All statistical analyses were carried out using SPSS for Windows v.11.5 at a significance level of p<0.05. The Pearson and Spearman’s Rho correlation coefficient was used to assess the correlation between Lp(a), LpPLA2 and oxLDL. Obese men with acute inflammation (hsCRP > 10 mg/L), renal failure (Creatinine >1.5 mg/dL) and consumed antiinflammation were excluded from this study.
RESULTS: The concentration of LpPLA2 had a linear correlation (r=-0.340, p=0.003) with the increase of oxLDL concentration. However, concentration of Lp(a) did not have linear correlation (r = 0.025) with increase of oxLDL concentration. This finding indicates that concentration of LpPLA2 had a negative correlation with increase of concentration of oxLDL. In addition, Lp(a) appears not to correlate with oxLDL significantly.
CONCLUSION: The study showed there was a significant correlation between concentration of LpPLA2 and concentration of oxLDL in men with central obesity. Higher concentration of LpPLA2 correlated with lower concentration of oxLDL.
KEYWORDS: Lp(a), LpPLA2, oxLDL, atherosclerosis, central obesity
Full Text:
PDFReferences
Koenig W, Khuseyinov N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol. 2007; 27: 15-26, CrossRef.
Scanu AM. Lp (a) lipoprotein – Coping with heterogeneity. N Engl J Med. 2003; 349: 2089-90, CrossRef.
MacPhee CH, Moores KE, Boyd HF, Dhanak D, Ife RJ, Leach CA, et.al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J. 1999; 338: 479-87, CrossRef.
McCormick PAS. Lipoprotein (a): biology and clinical importance. Clinical Biochemistry. 2004; 25: 69-80, PMID.
Ariyo AA, Chau Thach, and Tracy R. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Eng J Med. 2003; 349: 2108-15, CrossRef.
Iribarren C, Gross MD, Darbinian JA, Jacobs Jr DR, Sidney S, Loria C. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary artery calcification in young adults: the CARDIA study. Arterioscler Thromb Vasc Biol. 2005; 25: 216-21, CrossRef.
Bottalico LA, Keesla GA, Fless GM, Tobas I. Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation. J Biol Chem. 1993; 268: 8569-73, PMID.
Allen S, Khan S, Tam Sp, Koschinsky M, Taylor P, Yacoub M. Expression of adhesion molecules by Lp(a): A potential novel mechanism for its atherogenicity. FASEB J.1998; 12: 1765-76, PMID.
Bergmark C, Dewan A, Orsoni A, Merki S, Miller ER, Min-Jeong Shin, et al. A novel function of lipoprotein (a) as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res. 2008; 49: 2230-9, CrossRef.
Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease meta-analysis of prospective studies. Circulation. 2000; 102: 1082-5, CrossRef.
Syrovets T, Thillet J, Chapman MJ, Simmet T. Lipoprotein (a) is potent chemoattractant for human peripheral monocytes. Blood. 1997; 90: 2027-36, PMID.
Takami S, Yamashita S, Kihara S, Ishigami M, Takemura K, Kume N, et.al. Lipoprotein (a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. Circulation. 1998; 97: 721-8, CrossRef.
Cano EA. Structural basis for the pathophysiology of lipoprotein (a) in the athero-trombotic process. Brazilian J Med Bio Res. 1997; 30: 1271-80, CrossRef.
Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen, T, Breteler MM, et.al. Lipoprotein associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam study. Circulation. 2005; 111: 570-5, CrossRef.
Lerman A, McConnell JP. Lipoprotein-associated phospholipase A2: a risk marker or a risk factor? Am J Cardiol. 2008; 101: S11-22, CrossRef.
Sudhir K. Clinical review: lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease. J. Clin Endocrinol Metab. 2005; 90: 3100-5, CrossRef.
Persson M, Nilsson J, Nelson JJ, Hedblad B, Berglund G. The epidemiology of LpPLA2: distribution and correlation with cardiovascular risk factors in a population-based cohort. Atherosclerosis. 2007; 190: 388-96, CrossRef.
Karabina SAP, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD. PAF-acetylhidrolase activity of Lp(a) before and during Ce(2+)-induced oxidatived modification in vitro. Atherosclerosis. 1996; 125: 121-34, CrossRef.
Tsironis ID, Katsouras CS, Lourida E, Mitsios JV, Goudevenos J, Elisaf M, et al. Reduced PAF-acetyllhydrolase activity associate with Lp(a) patients with coronary artery disease. Atherosclerosis. 2004; 177: 193-201, CrossRef.
DOI: https://doi.org/10.18585/inabj.v3i1.134
Copyright (c) 2011 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
